Bellevue Group Ag Danaher Corp Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Danaher Corp stock. As of the latest transaction made, Bellevue Group Ag holds 105,590 shares of DHR stock, worth $24.1 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

105,590

Previous 83,920 25.82%

Holding current value

$24.1 Million

Previous $21 Million 39.99%

% of portfolio

0.49%

Previous 0.35%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $5.18 Million - $6.08 Million	21,670 Added 25.82%	105,590 $29.4 Million
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $544,499 - $619,569	-2,312 Reduced 2.68%	83,920 $21 Million
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $431,642 - $492,397	1,922 Added 2.28%	86,232 $21.5 Million
Q4 2023 Feb 14, 2024	SELL	$185.1 - $233.13 $9.67 Million - $12.2 Million	-52,223 Reduced 38.25%	84,310 $19.5 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $11 Million - $12.5 Million	-47,176 Reduced 25.68%	136,533 $33.9 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $34.6 Million - $39.4 Million	-153,682 Reduced 45.55%	183,709 $44.1 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $6.94 Million - $8.02 Million	-28,959 Reduced 7.9%	337,391 $85 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $261,940 - $306,284	-1,085 Reduced 0.3%	366,350 $97.3 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $839,756 - $5.12 Million	3,399 Added 0.93%	367,435 $94.9 Million
Q2 2022 Aug 11, 2022	BUY	$237.11 - $299.66 $1.65 Million - $2.09 Million	6,974 Added 1.95%	364,036 $92.3 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $60.4 Million - $74.1 Million	-234,738 Reduced 39.67%	357,062 $105 Million
Q4 2021 Feb 10, 2022	BUY	$292.08 - $329.01 $39.5 Million - $44.5 Million	135,121 Added 29.59%	591,800 $195 Million
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $7.15 Million - $8.73 Million	-26,261 Reduced 5.44%	456,679 $139 Million
Q2 2021 Aug 12, 2021	BUY	$225.08 - $271.69 $2.21 Million - $2.66 Million	9,800 Added 2.07%	482,940 $130 Million
Q1 2021 May 12, 2021	SELL	$212.38 - $245.9 $12.9 Million - $14.9 Million	-60,654 Reduced 11.36%	473,140 $106 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $17.1 Million - $19.7 Million	80,410 Added 17.74%	533,794 $119 Million
Q3 2020 Nov 16, 2020	BUY	$177.16 - $215.33 $310,207 - $377,042	1,751 Added 0.39%	453,384 $97.6 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $13.7 Million - $18.8 Million	106,152 Added 30.73%	451,633 $79.9 Million
Q1 2020 May 14, 2020	SELL	$121.39 - $169.05 $2.56 Million - $3.57 Million	-21,112 Reduced 5.76%	345,481 $47.8 Million
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $690,039 - $793,491	-5,170 Reduced 1.39%	366,593 $56.3 Million
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $2.85 Million - $3.09 Million	21,065 Added 6.01%	371,763 $53.7 Million
Q2 2019 Aug 14, 2019	BUY	$124.88 - $143.73 $1.11 Million - $1.28 Million	8,914 Added 2.61%	350,698 $50.1 Million
Q1 2019 May 15, 2019	BUY	$97.62 - $132.29 $867,646 - $1.18 Million	8,888 Added 2.67%	341,784 $45.1 Million
Q4 2018 Feb 12, 2019	BUY	$94.85 - $109.54 $7.58 Million - $8.75 Million	79,880 Added 31.57%	332,896 $34.3 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $3.39 Million - $3.76 Million	34,551 Added 15.82%	253,016 $27.5 Million
Q2 2018 Aug 07, 2018	BUY	$96.1 - $103.24 $1.58 Million - $1.7 Million	16,465 Added 8.15%	218,465 $21.6 Million
Q4 2017 Feb 14, 2018	BUY	$85.26 - $94.62 $3.68 Million - $4.09 Million	43,200 Added 27.2%	202,000 $18.8 Million
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $1.25 Million - $1.4 Million	15,800 Added 11.05%	158,800 $13.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	143,000	143,000 $12.1 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $166B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Danaher Corp Transaction History